Lymphocyte Subsets in COVID-19 Patients
Author Information
Author(s): Daenen Katrijn, van Hooijdonk Samantha, Tong-Minh Kirby, Dik Willem A., van Hagen Petrus M., Huijben Jilske A., Gommers Diederik, van Gorp Eric C. M., Endeman Henrik, Dalm Virgil A. S. H.
Primary Institution: Erasmus University Medical Center
Hypothesis
Differences in lymphocyte subsets are associated with severe or fatal COVID-19 disease.
Conclusion
Lymphocyte subsets were not significantly different between SARS-CoV-2 negative and positive patients and between mild versus severe cases.
Supporting Evidence
- Twenty-five SARS-CoV-2 negative and 77 SARS-CoV-2 positive patients were included.
- 57 patients had mild COVID-19 and 20 had severe COVID-19.
- Prior use of immunosuppressive drugs was not associated with COVID-19 severity.
Takeaway
The study looked at blood cells in COVID-19 patients to see if they could predict how sick someone might get, but found no clear differences.
Methodology
Patients were included from the emergency department, and lymphocyte subsets were analyzed within 24 hours of presentation.
Potential Biases
The study may not fully represent the most severe cases due to exclusion criteria.
Limitations
Patients directly transferred to ICU were excluded, potentially omitting the most critically ill.
Participant Demographics
The majority of patients were male, with a mean age of 58 years.
Statistical Information
P-Value
p<0.05
Confidence Interval
0.355-3.194
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website